These stocks offer growth at a reasonable price as the second quarter kicks off
Growth at a reasonable price, or GARP, opportunities exist across a variety of stock groups, CNBC found. Source link
Read More
Cigna Corp
Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet
Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say
Read More
Stocks making the biggest moves midday: Meta, Apple, Intel, Amazon, Clorox and more
These are some of the stocks posting the largest moves in midday trading. Source link
Read More
Stocks making the biggest premarket moves: Meta, Amazon, Bristol-Myers Squibb, Chevron and more
Names on the move ahead of the open. Source link
Read More
Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs
The medical cost increases reflect an increasing number of older adults returning to hospitals to undergo procedures they had delayed
Read More
Eli Lilly’s direct drug sales alone may not upend the industry, but others could follow suit
LillyDirect is the latest attempt to simplify what critics call a complex system for distributing, pricing and prescribing prescription drugs.
Read More
Here are the big health sector themes to watch next year
The health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have
Read More
Stocks making the biggest moves midday: Macy’s, Cigna Group, Eli Lilly, Paramount and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
Cigna abandons pursuit of Humana, plans $10 billion share buyback, sources say
U.S. health insurer Cigna has ended its attempt to negotiate an acquisition of peer Humana, two sources familiar with the
Read More